Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers.

Li T, Santockyte R, Shen RF, Tekle E, Wang G, Yang DC, Chock PB.

Arch Biochem Biophys. 2006 Sep 1;453(1):70-4. Epub 2006 Mar 20.

PMID:
16620772
2.

Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways.

Schulman BA, Harper JW.

Nat Rev Mol Cell Biol. 2009 May;10(5):319-31. doi: 10.1038/nrm2673. Epub 2009 Apr 8. Review.

3.

SUMO conjugation and cardiovascular development.

Wang J.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1219-29. Review.

PMID:
19273126
4.

NEDD8 pathways in cancer, Sine Quibus Non.

Watson IR, Irwin MS, Ohh M.

Cancer Cell. 2011 Feb 15;19(2):168-76. doi: 10.1016/j.ccr.2011.01.002. Review.

5.

DeSUMOylating enzymes--SENPs.

Drag M, Salvesen GS.

IUBMB Life. 2008 Nov;60(11):734-42. doi: 10.1002/iub.113. Review.

6.

Protein modification by SUMO.

Johnson ES.

Annu Rev Biochem. 2004;73:355-82. Review.

PMID:
15189146
7.

Structural attributes in the conjugation of ubiquitin, SUMO and RUB to protein substrates.

Goettsch S, Bayer P.

Front Biosci. 2002 Aug 1;7:a148-62. Review.

PMID:
12133807
8.

Novel substrates and functions for the ubiquitin-like molecule NEDD8.

Xirodimas DP.

Biochem Soc Trans. 2008 Oct;36(Pt 5):802-6. doi: 10.1042/BST0360802. Review.

PMID:
18793140
9.

ISG15: the immunological kin of ubiquitin.

Ritchie KJ, Zhang DE.

Semin Cell Dev Biol. 2004 Apr;15(2):237-46. Review.

PMID:
15209384
10.

Ubiquitin-like protein modifiers and their potential for antiviral and anti-HCV therapy.

Chen L, Li S, Li Y, Duan X, Liu B, McGilvray I.

Expert Rev Proteomics. 2013 Jun;10(3):275-87. doi: 10.1586/epr.13.15. Review.

PMID:
23777217
11.

Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins.

Rodríguez JA.

Semin Cancer Biol. 2014 Aug;27:11-9. doi: 10.1016/j.semcancer.2014.03.005. Epub 2014 Apr 3. Review.

PMID:
24704338
12.

Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest.

Ulrich HD.

Trends Cell Biol. 2005 Oct;15(10):525-32. Epub 2005 Aug 25. Review.

PMID:
16125934
13.

Ubiquitin-like modifications in the DNA damage response.

Wang Z, Zhu WG, Xu X.

Mutat Res. 2017 Oct;803-805:56-75. doi: 10.1016/j.mrfmmm.2017.07.001. Epub 2017 Jul 11. Review.

PMID:
28734548
14.

Ubiquitin-like protein activation.

Huang DT, Walden H, Duda D, Schulman BA.

Oncogene. 2004 Mar 15;23(11):1958-71. Review.

PMID:
15021884
15.

Modification by ubiquitin-like proteins: significance in apoptosis and autophagy pathways.

Cajee UF, Hull R, Ntwasa M.

Int J Mol Sci. 2012;13(9):11804-31. doi: 10.3390/ijms130911804. Epub 2012 Sep 19. Review.

16.

Ubiquitylation and isgylation: overlapping enzymatic cascades do the job.

Staub O.

Sci STKE. 2004 Aug 3;2004(245):pe43. Review.

PMID:
15304665
17.

Ubiquitin-like modifiers.

Taherbhoy AM, Schulman BA, Kaiser SE.

Essays Biochem. 2012;52:51-63. doi: 10.1042/bse0520051. Review.

PMID:
22708563
18.

The enzymes in ubiquitin-like post-translational modifications.

Chen Y.

Biosci Trends. 2007 Aug;1(1):16-25. Review.

19.

The dual role of ubiquitin-like protein Urm1 as a protein modifier and sulfur carrier.

Wang F, Liu M, Qiu R, Ji C.

Protein Cell. 2011 Aug;2(8):612-9. doi: 10.1007/s13238-011-1074-6. Epub 2011 Sep 9. Review.

Supplemental Content

Support Center